Search results
In a pandemic milestone, the NIH ends guidance on COVID treatment
NPR· 50 minutes agoCliff Lane, director of the clinical research division at the National Institute of Allergy and...
NIH Scientists Find Weak Points on Epstein-Barr Virus, New Details of EBV Protein Could Aid...
Sierra Sun Times· 5 days agoThe research was led by Jeffrey I. Cohen, M.D., and colleagues from the National Institute of...
Clemastine Tied to Worsening Symptoms in Multidrug MS Trial
Medscape· 5 days agoAn over-the-counter (OTC) antihistamine that had shown potential for treatment of multiple sclerosis...
This Virus Infects Around 95 Percent Of Us – And Its Weak Spots Have Now Been Found
IFLScience· 6 days agoEpstein-Barr Virus (EBV) has no available vaccine or cure – but that may not be the case forever....
Study finds no persistent cough in four out of five individuals with tuberculosis in Africa and Asia
Medical Xpress· 7 days agoMore than 80% of patients with tuberculosis, the world's most deadly infection, do not have a...
Published Data Show Why GSK Bailed on Its Maternal RSV Vaccine
MedPage Today· 6 days agoGSK's abandoned maternal respiratory syncytial virus (RSV) vaccine protected infants from severe...
SIGA Technologies, Inc. (NASDAQ:SIGA) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoSIGA Technologies, Inc. (NASDAQ:SIGA) Q4 2023 Earnings Call Transcript March 13, 2024 SIGA...
Vac to the future
Newswise· 5 days agoScientists at La Jolla Institute for Immunology (LJI) recently published the results of a competition that put researchers to the test. For the...
Estimated risk of mpox hospitalization 4% in UK epidemic, with higher risk in women
Center for Infectious Disease Research and Policy· 7 days agoFor women, the estimated sample case hospitalization risk was 18%, compared with 5% for men, but the...
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
WCMH Columbus· 4 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...